Ye Hong

Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients

Juan Wang, Xiaofei Sun, Jia Zhu, 2023, Scientific Reports.

A Pan-Cancer Analysis of Prognostic and Immunological Roles for Cell Death Genes

Yan Yuan, Yizhuo Zhang, Zexian Liu, 2023, Genes.

Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study

Juan Wang, Z. Zhen, Xiaofei Sun, 2023, Frontiers in Pharmacology.

Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China

Juan Wang, Z. Zhen, Yu Zhang, 2023, Frontiers in Immunology.

The dual HDAC and PI3K inhibitor, CUDC-907, inhibits tumor growth and stem-like properties by suppressing PTX3 in neuroblastoma

Z. Zhen, Suying Lu, F. Sun, 2023, International journal of oncology.

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma

Suying Lu, F. Sun, Yan Tang, 2023, Oncoimmunology.